NOS1 and retinitis pigmentosa 1: Results including 29 animal studies and three human trials (post-RP patients) revealed a significant increase in histological and molecular parameters of response, including nNOS, smooth muscle content and anti-apoptotic activity in rats, and an improvement in IEEF and EHS in human studies.